초록 ▼

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

대표청구항 ▼

1. A method of treating inflammation in a mammal, which comprises: acquiring Morinda citrifolia leaves;cutting the leaves into small pieces;placing the leaves into a crushing device;crushing the leaves;percolating the leaf pieces in an alcohol solution;collecting the alcohol and all alcohol soluble

1. A method of treating inflammation in a mammal, which comprises: acquiring Morinda citrifolia leaves;cutting the leaves into small pieces;placing the leaves into a crushing device;crushing the leaves;percolating the leaf pieces in an alcohol solution;collecting the alcohol and all alcohol soluble ingredients from the alcohol leaf slurry;allowing the alcohol to evaporate leaving a primary leaf extract;dissolving the leaf extract in water; andadministering the diluted leaf extract to a mammal to decrease or prevent inflammation and/or pain. 2. The method of claim 1, wherein the leaf extract is dissolved in water to dilute the solution by an amount selected from a list consisting of: 10,000 milligrams per milliliter, 1000 milligrams per milliliter 100 milligrams per milliliter, 10 milligrams per milliliter, 1 milligram per milliliter, 0.1 milligrams per milliliter, 0.001 milligrams per milliliter, and 0.0001 milligrams per milliliter. 3. The method of claim 1, wherein the primary leaf extract is pasteurized. 4. The method of claim 1, wherein the primary leaf extract is partially sterilized. 5. The method of claim 1, further comprising a step of placing the primary leaf extract in a centrifuge to remove any remaining leaf juice and other materials, including chlorophyll. 6. The method of claim 1, wherein the primary leaf extract is further fractionated into a secondary fraction selected from a list consisting of: a dry hexane fraction; andan aqueous methanol fraction. 7. The method of claim 6, wherein the secondary fractions are produced utilizing a gas chromatograph containing silicone dioxide. 8. The method of claim 6, further comprising the steps of dividing the secondary methanol fraction into additional methanol fractions. 9. The method of claim 6, wherein the secondary hexane fraction is further fractionated into additional hexane fractions. 10. The method of claim 1, further comprising a step of combining the leaf extract with the fruit juice of the fruit of the Morinda citrifolia plant to obtain a leaf serum. 11. The method of claim 2, further comprising the step of combining the primary extract with a carrier medium prior to administration. 12. The method of claim 1, wherein the diluted leaf extract to administered to the mammal to selectively inhabit Cyclooxygenase-2 relative to Cyclooxygenase-1. 13. The method of claim 1, wherein the decreasing or prevention of inflammation and/or pain is accomplished while maintaining gastric mucosal integrity. 14. The method of claim 1, further comprising the step of diluting the dissolved extract by 100-fold prior to administration. 15. The method of claim 1, wherein said active ingredient is selected from a list consisting of Pyro-phorbide a, Pheoporbide a, Purpin 7, and Pheophorbide Phytolester.